TrialAnnals of hematology2019

Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A.

Anita Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.